Acute DiseaseNCT01506180
In-Hospital Comprehensive Geriatric Assessment in Aged Acute Medical Patients
An observational study of Acute Disease, run by University of Aarhus at 1 site in Denmark.
Trial summary
The purpose of this study is to compare acute ill elderly medical patients in a geriatric department with general medical departments, and to examine the effects of comprehensive geriatric assessment in the geriatric setting compared with general medical care. Read more about this study
- Who is it for?
- Ages 80 years and older
- Conditions the study is for
- Acute Disease
- How many people
- 3,877 participants
- Where
- 1 siteDenmark
- Study dates
- Jan 2010to Nov 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 80 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Acute medical patients aged 80 years or older
Who may be able to join
- patients admitted to the departments of medicine at Aarhus University Hospital either through the emergency medical ward or directly to the medical wards in the period from January 1, 2009 to December 31, 2010.
Who cannot join
- patients admitted to the neurology-, cardiology-, nephrology- or haematology departments, and patients discharged directly to their homes from the emergency medical ward.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to compare acute ill elderly medical patients in a geriatric department with general medical departments, and to examine the effects of comprehensive geriatric assessment in the geriatric setting compared with general medical care.
Read the detailed description
Design:
- a cross-sectional study followed by 2) a subgroup study by retrospective follow-up
- Conditions
- Acute Disease
- Keywords
- acute medical care, comprehensive geriatric assessment, Health Services for the Aged, Geriatric Assessment, Geriatrics, Aged
- Medical subject headings
- Acute Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients admitted to Geriatric Department | The patients receive comprehensive geriatric assessment | |
| Patients admitted to general medical departments | This group do not receive comprehensive geriatric assessment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comorbidity
By Charlsons Comorbidity Index
Measured: At hospital admission (day 1)
Length of hospital stay
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
Measured: Number of days of hospitalization an expected average of 8 days
Secondary outcomes (2)
Acute readmission
The number of acute readmissions in the participants within 30 days and 90 days after the discharge, respectively.
Measured: 30 days and 90 days
Mortality
The number of short-term mortality in the participants within 30 days after hospital admission.
Measured: Within 30 days after hospital admission
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2012 (estimated)
- Study startJan 2010
- Primary completionNov 2011
- Study completionNov 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Acute DiseaseStudies of the same condition, open and under way.
- More trials run by University of AarhusThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 3,877 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Aarhus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merete Gregersen, University of Aarhus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01506180
- Sponsor's protocol ID
- CGA-GD-2011
- Status last verified
- Jan 2012
- First submitted
- 2 Nov 2011
- Last updated
- 9 Jan 2012
- Results posted
- No
- Data monitoring committee
- No
Publications
Gregersen M, Pedersen AB, Damsgaard EM. Comprehensive geriatric assessment increases 30-day survival in the aged acute medical inpatients. Dan Med J. 2012 Jun;59(6):A4442.
PubMed 22677240
Study at a glance
From the registry record, last updated by the sponsor on 9 Jan 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- In-Hospital Comprehensive Geriatric Assessment in Aged Acute Medical Patients
- ClinicalTrials.gov ID
- NCT01506180
- Acronym / sponsor ID
- CGA-GD-2011
- Conditions
- Acute Disease
- Keywords
- acute medical care, comprehensive geriatric assessment, Health Services for the Aged, Geriatric Assessment, Geriatrics, Aged
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,877 participants (actual)
- Lead sponsor
- University of AarhusUniversity, hospital or other
- Study start
- Jan 2010
- Primary completion
- Nov 2011 (actual)
- Study completion
- Nov 2011 (actual)
- First posted
- 9 Jan 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare acute ill elderly medical patients in a geriatric department with general medical departments, and to examine the effects of comprehensive geriatric assessment in the geriatric setting compared with general medical care.
Detailed description
Design:
- a cross-sectional study followed by 2) a subgroup study by retrospective follow-up
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients admitted to Geriatric Department | – | –The patients receive comprehensive geriatric assessment |
| Patients admitted to general medical departments | – | –This group do not receive comprehensive geriatric assessment |
Who may qualify
- Ages
- 80 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Acute medical patients aged 80 years or older
Key inclusion criteria (1 listed)
- patients admitted to the departments of medicine at Aarhus University Hospital either through the emergency medical ward or directly to the medical wards in the period from January 1, 2009 to December 31, 2010.
Key exclusion criteria (1 listed)
- patients admitted to the neurology-, cardiology-, nephrology- or haematology departments, and patients discharged directly to their homes from the emergency medical ward.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Comorbidity
Time frame: At hospital admission (day 1)
By Charlsons Comorbidity Index
Length of hospital stay
Time frame: Number of days of hospitalization an expected average of 8 days
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
2 secondary outcomes
Acute readmission
Time frame: 30 days and 90 days
Mortality
Time frame: Within 30 days after hospital admission
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jan 2012.
- Derived from this study: PubMed 22677240Gregersen M, Pedersen AB, Damsgaard EM. Comprehensive geriatric assessment increases 30-day survival in the aged acute medical inpatients. Dan Med J. 2012 Jun;59(6):A4442.
Related trials for Acute Disease
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Disease, run by University of Aarhus at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jan 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comorbidity (time frame: At hospital admission (day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01506180, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2012.